A landmark challenge to Australia's plain-packaging law for cigarettes and cigars at the WTO could have vast implications for how governments square the rules of trade with radical public health measures.
May 4, 2014
1
0
Even very young children understand what it means to steal a physical object, yet it appears to take them another couple of years to understand what it means to steal an idea.
Mar 11, 2014
1
0
(HealthDay)—Patients with poorly controlled diabetes have improvements in hemoglobin A1c and medication adherence and fewer trips to the emergency room after receiving daily text messages, according to a study published ...
Nov 22, 2013
0
0
Honduras on Friday raised the pressure on Australia over its landmark plain packaging rules for tobacco by launching a full-blown dispute at the World Trade Organization, the global body said.
Sep 13, 2013
0
0
International efforts to combat a new pneumonia-like virus that has now killed 22 people are being slowed by unclear rules and competition for the potentially profitable rights to disease samples, the head of the World Health ...
May 23, 2013
0
0
US scientists on Wednesday said they had used baker's yeast to make a key ingredient of malaria drugs, a feat that could iron out fluctuations in supply caused by sourcing the chemical from a Chinese herb.
Apr 10, 2013
0
0
A US-led Pacific free trade pact faces further delays as a row between Big Pharma and activists supporting access to generic drugs erupts ahead of an October deadline, officials say.
Mar 10, 2013
1
0
India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting inexpensive ...
Mar 5, 2013
3
0
A law forcing tobacco firms to sell cigarettes in plain packets came into effect in Australia on Saturday in an effort to strip any glamour from smoking and prevent young people from taking up the habit.
Dec 1, 2012
4
0
Pharmaceutical giant Bayer AG on Wednesday said it was "disappointed" with an Indian ruling that allows a local firm to produce a cheaper copy of its patented drug Nexavar for liver and lung cancer.
Sep 26, 2012
0
0
